Unusual Clinical Tumor Development in Axilla

Marie Strunová,J Haškovcová,J Kobilková,D Pavlišta,V Ulrych,M Janoušek

doi:10.14712/23362936.2014.23

Marie Strunová, J Haškovcová + Show 4 more

Open Access

https://doi.org/10.14712/23362936.2014.23

Copy DOI

Abstract

This work describes clinical development of a sarcoma in the left axilla of a 36-year-old woman. The macroscopic picture changed from the initial inflammatory reddening to globular resistance of 2.5 cm, suggestive of an enlarged lymph node. Mammography did not reveal any associated breast disease. Colliquation found on the ultrasound images led to a biopsy, the result of which indicated only an inflammation, without any malignancy. Rapid growth of the axillar tumor to 10 cm in size within 8 weeks prompted surgery allowing proper diagnosis of a small mature-to-immature sarcoma. Special examinations performed by a histopathologist (at the Institute for Histopathology) could not establish the precise histogenesis, i.e. the tissue origin. Therefore it was necessary to remove any clinically obscuring tumor for the final proper histological diagnosis and adequate treatment of the patient.

Highlights

In the personal anamnesis of our 36-year-old patient (G2/P2) no relation to the present ailment was found.The gynecological anamnesis showed two spontaneous child births, after the second birth a conization was performed, which had a histological finding of CIN 2
The patient was given local treatment, and subsequently the inflammation subsided. 3 weeks later the patient returned having found an axillar resistance which was movable with restrictions
The apparent inflammation was probably related to the tumor necrosis described by the surgeon at the axillar tumor surgery

Summary

Unusual Clinical Tumor Development in Axilla

Strunová M.1, Pavlišta D.1, Janoušek M.1, Haškovcová J.2, Ulrych V .3, Kobilková J.1 1Oncogynecological Centre, Department of Obstetrics and Gynaecology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic; 2Institute of Pathology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic; 3Multiscan, Oncological Clinic Pardubice, Pardubice, Czech Republic Recei ve d M ay 3 0 , 2 0 1 3 ; AcceptedAugust 1 4 , 2 0 1 3 .

Introduction

Discussion

Conclusion